StatPearls2026EN
StatPearls: Nonsteroidal Anti-Inflammatory Drugs Toxicity
Zusammenfassung
Nonsteroidal Anti-Inflammatory Drugs Toxicity - StatPearls - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. more... The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Home
Kerninformationen
ein Protein Clusters Protein Family Models PubChem BioAssay PubChem Compound PubChem Substance PubMed SNP SRA Structure Taxonomy ToolKit ToolKitAll ToolKitBookgh Search term Search Browse Titles Advanced Help Disclaimer --> NCBI Bookshelf. A service of the National Library of Medicine, National Inst...
025 . Continuing Education Activity Nonsteroidal anti-inflammatory drugs (NSAIDs) are a diverse class of medications that, despite chemical differences, share common therapeutic and adverse effects. They primarily alleviate inflammation, pain, and fever by inhibiting cyclooxygenase (COX) enzymes, wh...
ncreases during inflammatory states. While NSAIDs' inhibition of these enzymes underlies their therapeutic benefits, it also contributes to potential toxicities. This activity provides an updated review of the etiology, presentation, evaluation, and management of NSAID toxicity, highlighting the rol...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
BfArM2007
Nicht-steroidale Antirheumatika (NSAR): Aktualisierung der informativen Texte
StatPearls2026
StatPearls: Analgesic Nephropathy
AkdÄ2013
AkdÄ Bekanntgabe: Nichtsteroidale Antirheumatika (NSAR) im Vergleich: Risiko von Komplikationen im oberen Gastrointestinaltrakt, Herzinfarkt und Schlaganfall
BfArM2006
NSAID (nicht-selektive): Erneute Bewertung von kardiovaskulären Risiken sowie gesonderte Risikobewertung von Piroxicam
DGK (Deutsche Gesellschaft für Kardiologie)